Empyrean Medical Systems, Inc. is a global biotechnology company dedicated to advancing the delivery, accuracy, and clinical impact of cancer treatments for both patients and providers. Our innovative solutions and ongoing developments are focused on three principal areas: clinical and research radiation devices, radiopharmaceutical therapeutics, and an informatics platform with advanced AI and computational analytics. Our multi-pronged approach to quell cancer employs sophisticated technologies that are easy to use but will leverage advanced quantum physics, molecular biology and chemistry, engineering, and machine learning to provide unparalleled accurate and safe annihilation of cancer cells, predictive treatment planning, heightened safety and quality assurance, and collaborative research capabilities. We are striving to revolutionize cancer treatment… For Good!